JP Morgan | Whitepaper | Pharma Intelligence

Download Your Copy Now

Don't miss out on this comprehensive review of all the presentations from the conference, complied by our analysts, with key points and expert insight, for you to download, for free. A full list of events and catalysts that were announced or updated during the conference is included in this report.

Below are some of the key points from the conference’s presentations which are covered in detail in the full report:

Celgene (CELG) announced acquiring Impact Biomedicines and its late-stage myelofibrosis asset fedratinib
Regeneron Pharmaceuticals (REGN) announced the biggest news with an additional $1bn commitment from Regeneron and Sanofi towards cemiplimab
Pfizer highlighted H1 2018 milestones
Roche Holding’s (RHHBY) highlighted the company’s sixth consecutive year of sales growth
AbbVie (ABBV) focused on its flagship product, Humira
Spark Therapeutics (ONCE) announced a new gene therapy program